|Bid||0.5002 x 1200|
|Ask||0.5300 x 1000|
|Day's Range||0.5001 - 0.5450|
|52 Week Range||0.4800 - 1.4000|
|Beta (5Y Monthly)||-1.23|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 14, 2022 - Feb 18, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
AUSTIN, Texas, May 12, 2022--Astrotech Corporation reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.
AUSTIN, Texas, February 11, 2022--Astrotech Corporation (Nasdaq: ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.
AUSTIN, Texas, February 02, 2022--Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants.